Combat Methamphetamine Epidemic Act of 2005
E67391
The Combat Methamphetamine Epidemic Act of 2005 is a U.S. federal law that restricts retail sales of pseudoephedrine and related precursors to curb the domestic production of methamphetamine.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Combat Methamphetamine Epidemic Act of 2005 canonical | 3 |
How this entity was disambiguated
This entity first appeared as the object of triple T526720 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Combat Methamphetamine Epidemic Act of 2005 Context triple: [Controlled Substances Act, amendedBy, Combat Methamphetamine Epidemic Act of 2005]
-
A.
Comprehensive Methamphetamine Control Act of 1996
The Comprehensive Methamphetamine Control Act of 1996 is a U.S. federal law aimed at curbing the manufacture, distribution, and abuse of methamphetamine by tightening controls on precursor chemicals and enhancing law enforcement powers and penalties.
-
B.
Anti-Drug Abuse Act of 1988
The Anti-Drug Abuse Act of 1988 is a U.S. federal law that expanded the war on drugs by increasing penalties, funding enforcement and treatment programs, and establishing a coordinated national drug control strategy.
-
C.
Anti-Drug Abuse Act of 1986
The Anti-Drug Abuse Act of 1986 is a major U.S. federal law that significantly escalated the War on Drugs by establishing mandatory minimum sentences and harsher penalties for drug offenses, particularly involving crack cocaine.
-
D.
Drug-Free Schools and Communities Act amendments
The Drug-Free Schools and Communities Act amendments are U.S. federal legislative changes that strengthened requirements and funding for preventing drug and alcohol abuse in schools and on college campuses.
-
E.
Public Law 107-204
Public Law 107-204 is the formal designation of the Sarbanes–Oxley Act of 2002, a landmark U.S. federal law that overhauled corporate governance and financial reporting standards to combat accounting fraud.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Combat Methamphetamine Epidemic Act of 2005 Target entity description: The Combat Methamphetamine Epidemic Act of 2005 is a U.S. federal law that restricts retail sales of pseudoephedrine and related precursors to curb the domestic production of methamphetamine.
-
A.
Comprehensive Methamphetamine Control Act of 1996
The Comprehensive Methamphetamine Control Act of 1996 is a U.S. federal law aimed at curbing the manufacture, distribution, and abuse of methamphetamine by tightening controls on precursor chemicals and enhancing law enforcement powers and penalties.
-
B.
Anti-Drug Abuse Act of 1988
The Anti-Drug Abuse Act of 1988 is a U.S. federal law that expanded the war on drugs by increasing penalties, funding enforcement and treatment programs, and establishing a coordinated national drug control strategy.
-
C.
Anti-Drug Abuse Act of 1986
The Anti-Drug Abuse Act of 1986 is a major U.S. federal law that significantly escalated the War on Drugs by establishing mandatory minimum sentences and harsher penalties for drug offenses, particularly involving crack cocaine.
-
D.
Drug-Free Schools and Communities Act amendments
The Drug-Free Schools and Communities Act amendments are U.S. federal legislative changes that strengthened requirements and funding for preventing drug and alcohol abuse in schools and on college campuses.
-
E.
Public Law 107-204
Public Law 107-204 is the formal designation of the Sarbanes–Oxley Act of 2002, a landmark U.S. federal law that overhauled corporate governance and financial reporting standards to combat accounting fraud.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
United States federal law
ⓘ
drug control legislation ⓘ |
| addresses |
diversion of precursor chemicals
ⓘ
domestic methamphetamine production ⓘ |
| aimsTo |
prevent diversion of legal cold medicines to illicit drug manufacturing
ⓘ
protect public health and safety ⓘ reduce methamphetamine-related crime ⓘ |
| appliesTo |
retail sales of ephedrine
ⓘ
retail sales of phenylpropanolamine ⓘ retail sales of pseudoephedrine ⓘ |
| chemicalTarget |
ephedrine
ⓘ
phenylpropanolamine ⓘ pseudoephedrine ⓘ |
| country |
United States
ⓘ
linked to:
United States of America
|
| enforcedBy |
Drug Enforcement Administration
ⓘ
state and local law enforcement agencies ⓘ |
| hasEffect |
increased regulatory burden on retailers of pseudoephedrine products
ⓘ
reduced availability of precursor chemicals for methamphetamine production ⓘ |
| imposes |
30-day sales limits on pseudoephedrine purchases
ⓘ
daily sales limits on pseudoephedrine purchases ⓘ quantity limits on mail-order sales of pseudoephedrine ⓘ quantity limits on mobile vendor sales of pseudoephedrine ⓘ |
| legalArea |
controlled substances regulation
ⓘ
pharmaceutical regulation ⓘ |
| partOf | USA PATRIOT Improvement and Reauthorization Act of 2005 ⓘ |
| purpose |
to curb domestic production of methamphetamine
ⓘ
to restrict access to methamphetamine precursors ⓘ |
| regulates |
over-the-counter cold medicines containing ephedrine
ⓘ
over-the-counter cold medicines containing phenylpropanolamine ⓘ over-the-counter cold medicines containing pseudoephedrine ⓘ |
| relatedTo |
Controlled Substances Act
ⓘ
United States methamphetamine control policies ⓘ |
| requires |
customer identification for purchase of pseudoephedrine products
ⓘ
customer signature in a logbook for pseudoephedrine purchases ⓘ placement of pseudoephedrine products behind the counter ⓘ recordkeeping of pseudoephedrine sales by retailers ⓘ |
| sectorAffected |
over-the-counter drug manufacturers
ⓘ
pharmacies ⓘ retail stores ⓘ |
| shortName | CMEA ⓘ |
| subjectOf |
United States drug policy debates
ⓘ
linked to:
War on Drugs
public health discussions on methamphetamine abuse ⓘ |
| targets | methamphetamine production in clandestine laboratories ⓘ |
| typeOfRestriction |
point-of-sale controls
ⓘ
purchase quantity limits ⓘ recordkeeping requirements ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Combat Methamphetamine Epidemic Act of 2005 Description of subject: The Combat Methamphetamine Epidemic Act of 2005 is a U.S. federal law that restricts retail sales of pseudoephedrine and related precursors to curb the domestic production of methamphetamine.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.